Outcomes of active surveillance of clinical stage I non-seminomatous germ cell tumors: sub-analysis of the multi-institutional nationwide case series of the Japanese Urological Association-Reference-Cited by-同舟云学术

Outcomes of active surveillance of clinical stage I non-seminomatous germ cell tumors: sub-analysis of the multi-institutional nationwide case series of the Japanese Urological Association

Published:2018-04-17 Issue:6 Volume:48 Page:565-569
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Shinoda Yasuo¹^ORCID,Matsui Yoshiyuki¹,Fujimoto Hiroyuki¹,

Affiliation:

1. Urology Division, National Cancer Center Hospital, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/6/565/25536144/hyy051.pdf

Reference21 articles.

1. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from Cancer Registration Committee of the Japanese Urological Association;Miki;Int J Urol,2014

2. The changing distribution of stage in nonseminomatous germ cell tumors from 1977 to 1996;Sonneveld;BJU Int,1999

3. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): Modifications of technique and impact on ejaculation;Donohue;J Urol,1993

4. Surveillance or lymph node dissection in clinical stage I non-seminomatous germinal testis cancer?;Pizzocaro;Br J Urol,1985

5. Management of clinical stage I nonseminomatous germ cell testicular cancer;Choueiri;Urol Clin North Am,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review;World Journal of Urology;2022-09-15

2. Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review;World Journal of Urology;2022-07-29